Device Trial Radar · NCT02279979
Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Last checked: Nov 20, 2026Latest source record: Jul 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
9
Actual
Start
Oct 2014
Primary completion
Jan 2017
Study completion Jan 2017
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- Collaborators
- Thoratec Corporation
- First posted
- Oct 31, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess reasonable safety and performance of the HeartMate PHP to provide hemodynamic support for up to 72 hours in patients with cardiogenic shock requiring stabilization.
Conditions
- Cardiogenic Shock
Interventions
HeartMate PHPDevice
The HeartMate PHP system is a catheter-based heart pump and console designed to provide hemodynamic left ventricular support for up to 3 days to stabilize patients by maintaining adequate systemic cardiac output.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical stabilization defined as improvement of Cardiac Index to > 2.2 L/min/m2Time frame: 72 hours
Locations
6 sites in 4 countries. Site status is shown where the registry gives one.
Na Homolce Hospital
Prague, Czechia
Institute for Clinical and Experimental Medicine (IKEM)
Prague, Czechia
Universitätskliniken Düsseldorf
Düsseldorf, Germany
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.